StocksN › NOW

ServiceNow, Inc. (NOW) — Earnings Call X-Ray

Our AI read all 38 of NOW's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q2 2025 · sign up to see
Previous Call Grade
B
Q1 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2016–2025
Avg Candor
6.4/9
evasion 2.2/9
Guidance RaisedPromotional ToneSkeptic ReassuredCritic AmmunitionDeferred Revenue GrowingEarly Product, Fast GrowthMargins ExpandingBacklog Growing

Call-by-call analysis

🔒 Q2 2025 earnings call 2025-07-23 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q2 2025 call grade is ready
The full 37-point AI read of NOW's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

B Q1 2025 earnings call 2025-04-23 move ±24.8%

Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics, promotional in tone.

Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growing 15 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 8/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q4 2024 earnings call 2025-01-29 move ±17%

Management gave no formal guidance. The delivery was guarded, light on specifics.

7 analysts · 0 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsed
Candor 3/9
Specificity 1/9
Evasion 0/9
Confidence 5/9
Uncertainty 4/9
Promotion 4/9
Stress 2/9
Complexity 4/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

A Q3 2024 earnings call 2024-10-23 move ±11.7%

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingPricing: raisingHeadcount: growing 12 analysts · 16 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 6/9
Specificity 9/9
Evasion 2/9
Confidence 9/9
Uncertainty 1/9
Promotion 8/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q2 2024 earnings call 2024-07-24 move ±19.6%

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, promotional in tone.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingPricing: raisingHeadcount: growingCapex: increasing 15 analysts · 17 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 6/9
Specificity 8/9
Evasion 2/9
Confidence 9/9
Uncertainty 3/9
Promotion 9/9
Stress 4/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

B Q1 2024 earnings call 2024-04-24 move ±10.7%

Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: increasing 17 analysts · 18 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 5/9
Specificity 8/9
Evasion 3/9
Confidence 9/9
Uncertainty 2/9
Promotion 8/9
Stress 1/9
Complexity 3/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

A Q4 2023 earnings call 2024-01-24 move ±6.8%

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingPricing: raisingHeadcount: growingCapex: increasing 12 analysts · 14 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 6/9
Specificity 8/9
Evasion 2/9
Confidence 9/9
Uncertainty 3/9
Promotion 8/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

A Q3 2023 earnings call 2023-10-25 move ±11%

Management raised guidance against accelerating demand and expanding margins. The delivery was rich in specifics, relaxed under questioning, promotional in tone.

Guidance: raisedDemand: acceleratingMargins: expandingBacklog: growingHeadcount: growing 15 analysts · 16 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
Candor 6/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 7/9
Stress 1/9
Complexity 4/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q2 2023 2023-07-26 A raisedstableexpanding 6/9 3/9
Q1 2023 2023-04-26 B+ raisedstableexpanding 6/9 2/9
Q4 2022 2023-01-25 C+ maintainedstableexpanding 6/9 3/9
Q3 2022 2022-10-26 B+ raisedstablestable 6/9 3/9
Q2 2022 2022-07-27 C loweredstablestable 7/9 2/9
Q1 2022 2022-04-27 A raisedacceleratingstable 5/9 2/9
Q4 2021 2022-01-26 A maintainedacceleratingexpanding 7/9 1/9
Q3 2021 2021-10-27 A raisedacceleratingexpanding 6/9 3/9
Q2 2021 2021-07-29 A raisedacceleratingexpanding 6/9 2/9
Q1 2021 2021-04-29 A raisedacceleratingexpanding 6/9 2/9
Q4 2020 2021-01-28 A raisedacceleratingexpanding 6/9 2/9
Q3 2020 2020-10-29 A raisedacceleratingexpanding 7/9 2/9
Q2 2020 2020-07-29 A raisedacceleratingexpanding 6/9 2/9
Q1 2020 2020-04-29 C+ loweredmixedexpanding 7/9 2/9
Q4 2019 2020-01-29 B+ maintainedacceleratingexpanding 6/9 3/9
Q3 2019 2019-10-23 B+ raisedacceleratingstable 7/9 2/9
Q2 2019 2019-07-24 B+ raisedstablestable 7/9 3/9
Q1 2019 2019-04-24 A raisedacceleratingexpanding 7/9 3/9
Q4 2018 2019-01-30 B+ maintainedacceleratingexpanding 7/9 2/9
Q3 2018 2018-10-24 A raisedacceleratingexpanding 8/9 1/9
Q2 2018 2018-07-25 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2018 2018-04-25 A raisedacceleratingstable 7/9 2/9
Q4 2017 2018-01-31 B+ maintainedacceleratingexpanding 7/9 3/9
Q3 2017 2017-10-25 A raisedacceleratingstable 7/9 3/9
Q2 2017 2017-07-27 A raisedacceleratingstable 8/9 1/9
Q1 2017 2017-04-27 A raisedacceleratingexpanding 7/9 2/9
Q3 2016 2016-10-27 A raisedacceleratingexpanding 7/9 2/9
Q2 2016 2016-07-28 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2016 2016-04-20 A raisedacceleratingexpanding 7/9 2/9
Q4 2015 2016-01-27 B maintainedstableexpanding 8/9 2/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of NOW's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

A Q2 2023 earnings call 2023-07-26

A Q1 2017 earnings call 2017-04-27

1 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

A · Agilent Technologies, InAAFRF · Airtel Africa PlcAAIC · Arlington Asset InvestmeAAUKF · Anglo American plcAB · AllianceBernstein HoldinABC · AmerisourceBergen Corpor

NOVT   All “N” companies    NP

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.